
Home » German CMO Warned for Poor cGMP Training, Employee ‘Performance Lapses’
German CMO Warned for Poor cGMP Training, Employee ‘Performance Lapses’
Improper staff training at Hameln Pharmaceuticals’ new state-of-the-art, sterile plant in Hameln, Germany, has given rise to employee “performance lapses,” a recently posted warning letter states. These lapses caused “significant violations” of good manufacturing practice regulations, it adds.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
08Sep
-
15Sep
-
20Sep
-
21Sep
-
22Sep
-
11Oct